NOVELLA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 653
EU - Europa 519
AS - Asia 307
OC - Oceania 2
SA - Sud America 2
Totale 1.483
Nazione #
US - Stati Uniti d'America 648
CN - Cina 264
GB - Regno Unito 146
SE - Svezia 106
IE - Irlanda 70
FR - Francia 53
IT - Italia 48
DE - Germania 33
FI - Finlandia 27
SG - Singapore 18
UA - Ucraina 12
BE - Belgio 11
CA - Canada 4
JP - Giappone 4
KR - Corea 4
NL - Olanda 4
VN - Vietnam 4
PK - Pakistan 3
RU - Federazione Russa 3
AU - Australia 2
TR - Turchia 2
TW - Taiwan 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
ES - Italia 1
GE - Georgia 1
HU - Ungheria 1
IN - India 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.483
Città #
Chandler 179
Southend 138
Ann Arbor 71
Beijing 71
Dublin 70
Jacksonville 48
Ashburn 33
New York 33
Jinan 31
Lawrence 24
Princeton 24
Helsinki 22
Nanjing 18
Wilmington 17
Dearborn 16
Hebei 14
Shenyang 13
Ningbo 12
Brussels 11
Verona 11
Woodbridge 11
Hangzhou 10
Zhengzhou 9
Singapore 8
Tianjin 8
Haikou 7
Sindelfingen 7
Changsha 6
Jiaxing 6
Taiyuan 6
Fuzhou 5
Norwalk 5
Buffalo 4
Dong Ket 4
Guangzhou 4
Nanchang 4
Redwood City 4
Seoul 4
Tokyo 4
Amsterdam 3
Bologna 3
Fairfield 3
Islamabad 3
Redmond 3
San Francisco 3
Seattle 3
Washington 3
Columbus 2
Dongguan 2
Düsseldorf 2
Los Angeles 2
Milan 2
Newark 2
Ottawa 2
Taizhou 2
Ternate 2
Trento 2
Bishkek 1
Boardman 1
Boydton 1
Canberra 1
Chicago 1
Conco 1
Des Moines 1
Dhaka 1
Hendon 1
Jeddah 1
Kemerovo 1
Kent 1
Lanzhou 1
Lisbon 1
London 1
Mainz 1
Markham 1
Montréal 1
Nijmegen 1
Ospedaletto Euganeo 1
Paris 1
Puxian 1
Riga 1
Riva 1
Saint Petersburg 1
Santiago Metropolitan 1
Santo Domingo Este 1
Skopje 1
Sofia 1
Sopron 1
Tbilisi 1
Xiangfen 1
Totale 1.048
Nome #
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 99
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 90
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 88
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 85
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression 83
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 82
Liver Metastases From Renal Oncocytoma With Vascular Extension 79
Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set 78
Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study 73
Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection 66
Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer 58
Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: A large retrospective study 57
The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy 57
Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy 56
Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases 53
Linear extent of positive surgical margin impacts biochemical recurrence after robot-assisted radical prostatectomy in a high-volume center 52
Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients 52
External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers 49
Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set 48
Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors 47
The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection 46
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study 45
TRANSRECTAL VERSUS TRANSPERINEAL 14-CORE PROSTATE BIOPSY IN DETECTION OF PROSTATE CANCER: A COMPARATIVE EVALUATION AT THE SAME INSTITUTION 38
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 35
American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien-Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center 23
American Society of Anesthesiologists' (ASA) Physical Status System and Risk of Major Clavien-Dindo Complications After Robot-Assisted Radical Prostatectomy at Hospital Discharge: Analysis of 1143 Consecutive Prostate Cancer Patients 18
Totale 1.557
Categoria #
all - tutte 5.696
article - articoli 5.696
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 0 12
2019/2020184 21 0 3 7 15 25 29 8 15 20 13 28
2020/2021187 22 30 12 46 21 21 4 0 2 7 16 6
2021/2022199 18 51 2 32 8 5 4 12 6 5 8 48
2022/2023504 33 54 39 72 46 127 2 46 58 1 12 14
2023/2024248 7 23 17 30 28 53 14 13 1 25 36 1
Totale 1.557